Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Case #2: TAVR ViV With SAPIEN 3 (With Discussion)

Case #1: Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Implantation: Concept to First-in-Human BASILICA Procedures (With Discussion)

Case #3: A TAVR Gone Wrong (With Discussion)

Conclusions and Take-home Messages

Slovakia Comments: How Would I Treat This Case?

Poland Comments: How Would I Treat This Case?

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores – Potential Benefits and Harms